Quantcast
Connect with us

WATCH: Ex-hedge funder who hiked AIDS pill cost by 5,500 percent says drug ‘still underpriced’

Published

on

Appearing on Bloomberg TV, the CEO of a pharmaceutical company that recently hiked the price of a drug used for critically ill infants and AIDS patients by 5,500 percent , defended the price increase by promising better things to come for future patients.

Martin Shkreli, 32, the founder and chief executive of Turing Pharmaceuticals, recently purchased the rights to Daraprim and immediately increased the cost from $13.50 to $750 per pill.

ADVERTISEMENT

Asked why the huge increase in cost, Shkreli explained that the old companies who owned the drug were “practically giving it away almost,” and he needs to turn a profit.

Noting that the pill sold for $13.50 and the course of treatment “to save your life was only a $1,000,” Shrkeli said he had to make a change.

“We know, these days, in modern pharmaceuticals, cancer drugs can cost $100,000 or more, whereas these drugs can cost a half of a million dollars,” he explained. “Daraprim is still under-priced relative to its peers.”

RELATED:
‘He looks like a spoiled brat’: Not even Donald Trump likes price-gouging ‘pharma bro’ Martin Shkreli
These 37 tweets show how the pharma CEO gouging AIDS patients is even worse than you think
Pharmaceutical CEO: $750 is a ‘more appropriate’ price for $13 AIDS medicine

Asked if the pill really only costs $1 to manufacture, Shkreli agreed and said, “It costs very little to make Daraprim.”

ADVERTISEMENT

Shkreli then listed off manufacturing, distribution, and FDA costs as well as paying the people “who make it to specifications.”

Pressed even further on the $750 cost per pill, the CEO defended the price by noting how much it brought into the pharmaceutical company annually.

“This drug was making $5 million in revenue,” he said with a smile. “And I don’t think you can find a drug company on this planet that can make money on $5 million in revenue.”

ADVERTISEMENT

Shkreli stated that the drug is made for a “very very tough disease.”

“It requires a lot of attention and focus. The drug company needs to partner with the patients and make sure that it’s a very cared for community. And that costs a lot of money too,” pointing out that the company also “gives away” the drug for $1 for those who can’t afford it.

ADVERTISEMENT

Shkreli added: “Patients now have a powerful ally in our company.”

Watch video below from Bloomberg TV:

ADVERTISEMENT


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

Matt Gaetz forgot which network he was on: Surprised CNN anchor said ‘I’ve never been called Sean Hannity’

Published

on

Rep. Matt Gaetz seemed to confuse cable news networks during a Thursday appearance

Gaetz was interviewed by CNN's Chris Cuomo, who aggressively challenged Gaetz on the facts as the Florida Republican attempted to defend President Donald Trump.

Despite the fact Cuomo's interview was nothing like the puff segments Gaetz is used to on Fox, the congressman seemed confused by the end.

"Congressman, you are always welcome, wherever I am, at nine or eleven, whenever," Cuomo said.

"Thanks Sean," Gaetz replied.

"Did you just call me Sean?" Cuomo asked. "Did you just call me Sean?"

Continue Reading

Breaking Banner

Internet debates ‘the dumbest thing Brian Kilmeade has ever said’

Published

on

Fox News personality Brian Kilmeade has received a great deal of attention -- and criticism -- during the Trump era.

Kilmeade co-hosts one of the President's favorite shows, "Fox and Friends," with Steve Doocy and Ainsley Earhardt on weekday mornings. He also a show on the Fox News Radio network and frequently appears on "The Five."

The former Ultimate Fighting Championship play-by-play sportscaster has also been harshly criticized for the type of comments that make the show a favorite for the president.

Journalist Molly Jong-Fast, who was widely praised her interview of Lisa Page, decided to explore Kilmeade's comments.

Continue Reading
 

Facebook

Giuliani’s potential witness tampering in Ukraine is impossible to separate from Trump: Judiciary Democrat

Published

on

On Thursday's edition of MSNBC's "The Beat," Rep. Eric Swalwell (D-CA) broke down how Rudy Giuliani's misconduct in Ukraine is "inseparable" from President Donald Trump's.

"To everyone who asks whether we are moving too quickly, I say the president's lawyer is moving quickly to continue to ask a foreign government to cheat our elections, and doing nothing is completely off the table," said Swalwell, who sits on the House Intelligence and Judiciary Committees, the two most crucial committees in the impeachment inquiry. "We have to secure our elections. We have powerful, uncontradicted evidence now. And now is the time to hold the president accountable and determine just which impeachment articles we should proceed with."

Continue Reading